CJC-1295 With DAC: 5mg x10 Vials

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analogue featuring covalent albumin binding for extended serum half-life. Australian preclinical research investigates prolonged GHRH receptor activation, sustained IGF-1 elevation dynamics, and tissue-specific anabolic signalling over extended study periods in controlled laboratory models.

No. CJC-1295 With DAC is strictly for laboratory research only. Not for human consumption, therapeutic use or diagnostic procedures. Australian researchers must confirm legitimate research use at the time of purchase.

Refer to product documentation for specific storage guidance. In general, store lyophilised CJC-1295 With DAC in a freezer. After reconstitution with bacteriostatic water, refrigerate and follow the usage timeframe in the product documentation. Protect from light, moisture, and temperature fluctuation. Use standard aseptic technique in a controlled laboratory environment.

Availability varies by product and batch. Where independent testing is complete, batch-specific Certificates of Analysis are available on request.

Dispatched within 1–3 business days from our international fulfilment partners in discrete, temperature-protected packaging. Estimated delivery is 5–9 days from order, processing included, express with a carrier tracking number Australia-wide. Free over $700 AUD. Every order ships express with a carrier tracking number emailed on dispatch. Trial vials are faster: they ship from domestic stock via Australia Post Express, same-day dispatch before 3 PM AEST, arriving in 2–3 business days.